Title of article :
The Benefit Of Chemotherapy In A Patient With Gastric Medullary Cancer
Author/Authors :
SEKER, Mehmet Metin Cumhuriyet University - Faculty of Medicine - Department of Medical Oncology, Turkey , YAZICI, Ozan Numune Research and Education Hospital - Department of Medical Oncology, Turkey , TURHAN, Nesrin Numune Research and Education Hospital - Department of Pathology, Turkey , AKSOY, Sercan Hacettepe University - Faculty of Medicine - Department of Medical Oncology, Turkey , KACAN, Turgut Cumhuriyet University - Faculty of Medicine - Department of Medical Oncology, Turkey , BABACAN, Nalan A. Cumhuriyet University - Faculty of Medicine - Department of Medical Oncology, Turkey , OZDEMIR, Nuriye Y. Numune Research and Education Hospital - Department of Medical Oncology, Turkey , UNCU, Dogan Numune Research and Education Hospital - Department of Medical Oncology, Turkey , ZENGIN, Nurullah Numune Research and Education Hospital - Department of Medical Oncology, Turkey
From page :
45
To page :
47
Abstract :
Undifferentiated gastric carcinomas with few glandular structures and scanty stroma are called “medullary type gastric carcinoma (MGC) ”. MGC is very rare in Turkey and in Western countries. So there is limited data about the choice of chemotherapy for MGC. Here, we present a sixty-eight years old female MGC patient treated with surgery and adjuvant fluorouracil and leucovorin chemotherapy. Subtotal gastrectomy was performed. Dense lymphocytes and plasma cells containing scanty stroma and neoplastic cell clusters with tubuler differentiation were detected at the pathological examination. Six course of fluorouracil and folinic acid had been applied as adjuvant chemotherapy. She had no relapse until the 30 months of follow up. MGC is commonly seen in the sixth decade and had a male predominance. The disease tends to be located in distal parts of the stomach. Mean tumor size for MGC is bigger than well-differentiated gastric adeno carcinoma but smaller than scirrhous type gastric adeno carcinoma. Based on the successful experience in the present case, here we suggest the use of fluoropyrimidine based therapies in the early stage of MGC.
Keywords :
Chemotherapy , gastric medullary cancer , prognosis
Journal title :
Acta Medica
Journal title :
Acta Medica
Record number :
2621124
Link To Document :
بازگشت